Hsbc Holdings PLC Evolus, Inc. Transaction History

Hsbc Holdings PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.76 - $13.72 $717,427 - $1.27 Million	-92,452 Reduced 88.3%	12,256 $98,000
Q2 2022 Aug 11, 2022	BUY	$10.22 - $13.94 $1.07 Million - $1.46 Million	104,708 New	104,708 $1.21 Million
Q1 2022 May 16, 2022	SELL	$5.22 - $11.78 $55,128 - $124,408	-10,561 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.37 - $8.38 $56,712 - $88,501	10,561 New	10,561 $68,000
Q1 2021 May 14, 2021	SELL	$3.2 - $16.51 $59,222 - $305,550	-18,507 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.92 - $4.84 $54,040 - $89,573	18,507 New	18,507 $62,000
Q4 2019 Feb 14, 2020	SELL	$11.58 - $17.37 $137,037 - $205,556	-11,834 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$13.91 - $19.87 $41,771 - $59,669	-3,003 Reduced 20.24%	11,834 $185,000
Q2 2019 Aug 13, 2019	BUY	$13.19 - $28.36 $195,700 - $420,777	14,837 New	14,837 $217,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $561M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.